Skip to main content
Journal of Epidemiology and Community Health logoLink to Journal of Epidemiology and Community Health
. 1995 Feb;49(1):84–86. doi: 10.1136/jech.49.1.84

Screening for colorectal cancer: reasons for refusal of faecal occult blood testing in a general practice in England.

K A Hynam 1, A R Hart 1, S P Gay 1, A Inglis 1, A C Wicks 1, J F Mayberry 1
PMCID: PMC1060080  PMID: 7707012

Abstract

STUDY OBJECTIVE--To ascertain reasons for non-compliance with faecal occult blood tests in colorectal cancer screening programmes. DESIGN--A standard interview by a trained nurse of a random sample of those who declined screening. SETTING--The Leicestershire town of Market Harborough, where most of the 25,000 population are served by a single general practice of 10 partners. PARTICIPANTS--Altogether 4185 residents aged 51 to 70 years were invited to receive a free faecal occult blood test (Haemoccult). Eighty one subjects from a sample of 351 who wrote declining the offer were interviewed. MAIN RESULTS--Non-compliers were divided into those who did not request a test kit and those who returned an unused kit. In the former group the commonest reasons given were intercurrent illness (39%), fear of further tests and surgery (24%), and feeling well (22%). For those who returned unused kits the commonest reasons were the unpleasantness of the stool collection procedure (65%), feeling well (30%), intercurrent illness (23%), and fear of further tests and surgery (20%). In both groups the main concern of those who did not comply were fear of further diagnostic tests and surgery rather than concern at the lack of effective treatment for cancer. CONCLUSIONS--To increase compliance, education and publicity must explain the concept of asymptomatic illness and allay people's fear of hospital investigation and treatment. The benefits of screening should be particularly emphasised to those who return kits so they may overcome their reservations.

Full text

PDF
84

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkin W. S., Cuzick J., Northover J. M., Whynes D. K. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet. 1993 Mar 20;341(8847):736–740. doi: 10.1016/0140-6736(93)90499-7. [DOI] [PubMed] [Google Scholar]
  2. Farrands P. A., Griffiths R. L., Britton D. C. The Frome experiment--value of screening for colorectal cancer. Lancet. 1981 Jun 6;1(8232):1231–1232. doi: 10.1016/s0140-6736(81)92401-6. [DOI] [PubMed] [Google Scholar]
  3. Farrands P. A., Hardcastle J. D., Chamberlain J., Moss S. Factors affecting compliance with screening for colorectal cancer. Community Med. 1984 Feb;6(1):12–19. [PubMed] [Google Scholar]
  4. Hardcastle J. D., Thomas W. M., Chamberlain J., Pye G., Sheffield J., James P. D., Balfour T. W., Amar S. S., Armitage N. C., Moss S. M. Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects. Lancet. 1989 May 27;1(8648):1160–1164. doi: 10.1016/s0140-6736(89)92750-5. [DOI] [PubMed] [Google Scholar]
  5. Hobbs F. D., Cherry R. C., Fielding J. W., Pike L., Holder R. Acceptability of opportunistic screening for occult gastrointestinal blood loss. BMJ. 1992 Feb 22;304(6825):483–486. doi: 10.1136/bmj.304.6825.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hunter W., Farmer A., Mant D., Verne J., Northover J., Fitzpatrick R. The effect of self-administered faecal occult blood tests on compliance with screening for colorectal cancer: results of a survey of those invited. Fam Pract. 1991 Dec;8(4):367–372. doi: 10.1093/fampra/8.4.367. [DOI] [PubMed] [Google Scholar]
  7. Klaaborg K., Madsen M. S., Søndergaard O., Kronborg O. Participation in mass screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol. 1986 Dec;21(10):1180–1184. doi: 10.3109/00365528608996440. [DOI] [PubMed] [Google Scholar]
  8. Kronborg O., Fenger C., Søndergaard O., Pedersen K. M., Olsen J. Initial mass screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen in Denmark. Scand J Gastroenterol. 1987 Aug;22(6):677–686. doi: 10.3109/00365528709011142. [DOI] [PubMed] [Google Scholar]
  9. Lallemand R. C., Vakil P. A., Pearson P., Box V. Screening for asymptomatic bowel cancer in general practice. Br Med J (Clin Res Ed) 1984 Jan 7;288(6410):31–33. doi: 10.1136/bmj.288.6410.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Macrae F. A., Hill D. J., St John D. J., Ambikapathy A., Garner J. F. Predicting colon cancer screening behavior from health beliefs. Prev Med. 1984 Jan;13(1):115–126. doi: 10.1016/0091-7435(84)90044-6. [DOI] [PubMed] [Google Scholar]
  11. Mandel J. S., Bond J. H., Church T. R., Snover D. C., Bradley G. M., Schuman L. M., Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993 May 13;328(19):1365–1371. doi: 10.1056/NEJM199305133281901. [DOI] [PubMed] [Google Scholar]
  12. Million R., Howarth J., Turnberg E., Turnberg L. A. Faecal occult blood testing for colorectal cancer in general practice. Practitioner. 1982 Apr;226(1366):659–663. [PubMed] [Google Scholar]
  13. Muto T., Bussey H. J., Morson B. C. The evolution of cancer of the colon and rectum. Cancer. 1975 Dec;36(6):2251–2270. doi: 10.1002/cncr.2820360944. [DOI] [PubMed] [Google Scholar]
  14. Silman A., Mitchell P. Attitudes of non-participants in an occupational based programme of screening for colorectal cancer. Community Med. 1984 Feb;6(1):8–11. [PubMed] [Google Scholar]
  15. Spector M. H., Applegate W. B., Olmstead S. J., DiVasto P. V., Skipper B. Assessment of attitudes toward mass screening for colorectal cancer and polyps. Prev Med. 1981 Jan;10(1):105–109. doi: 10.1016/0091-7435(81)90011-6. [DOI] [PubMed] [Google Scholar]
  16. Stryker S. J., Wolff B. G., Culp C. E., Libbe S. D., Ilstrup D. M., MacCarty R. L. Natural history of untreated colonic polyps. Gastroenterology. 1987 Nov;93(5):1009–1013. doi: 10.1016/0016-5085(87)90563-4. [DOI] [PubMed] [Google Scholar]
  17. Winawer S. J., Andrews M., Flehinger B., Sherlock P., Schottenfeld D., Miller D. G. Progress report on controlled trial of fecal occult blood testing for the detection of colorectal neoplasia. Cancer. 1980 Jun 15;45(12):2959–2964. doi: 10.1002/1097-0142(19800615)45:12<2959::aid-cncr2820451212>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Epidemiology and Community Health are provided here courtesy of BMJ Publishing Group

RESOURCES